DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study

NCT ID: NCT06483113

Last Updated: 2025-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-26

Study Completion Date

2025-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study includes a Baseline visit and a Year 1 visit.

The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews.

The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a contact lens examination is performed. The Year 1 visit can be either retrospective or prospective in subjects 7 to less than 18 years of age. For subjects 18 years of age and older, the Year 1 visit will be retrospective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Hyperopia Presbyopia Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DAILIES TOTAL1 Sphere

Delefilcon A spherical soft contact lenses worn in both eyes in a real-world setting

Delefilcon A spherical soft contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)

DAILIES TOTAL1 Toric

Delefilcon A toric soft contact lenses worn in both eyes in a real-world setting

Delefilcon A toric soft contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism

DAILIES TOTAL1 Multifocal

Delefilcon A multifocal soft contact lenses worn in both eyes in a real-world setting

Delefilcon A multifocal soft contact lenses

Intervention Type DEVICE

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delefilcon A spherical soft contact lenses

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)

Intervention Type DEVICE

Delefilcon A toric soft contact lenses

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism

Intervention Type DEVICE

Delefilcon A multifocal soft contact lenses

Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DAILIES TOTAL1® Spherical Contact Lenses DAILIES TOTAL1® for Astigmatism Contact Lenses DAILIES TOTAL1® Multifocal Contact Lenses

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At baseline: 7 years of age or older for sphere and toric wearers, 40 years of age or older for multifocal wearers.
* Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
* Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.

Exclusion Criteria

* Any ocular disease or condition that would contraindicate contact lens wear at baseline.
* Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
Minimum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trial Lead, Vision Care

Role: STUDY_DIRECTOR

Alcon Research, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Westview Optometry

San Diego, California, United States

Site Status

Scripps Optometric Group

San Diego, California, United States

Site Status

Dr. Walker and Associates

Ponte Vedra Beach, Florida, United States

Site Status

Advanced Eyecare Specialists

West Palm Beach, Florida, United States

Site Status

The Eye Doctors Inc

Eden Prairie, Minnesota, United States

Site Status

Cornea and Contact Lens Institute of Minnesota

Edina, Minnesota, United States

Site Status

Complete Eye Care of Medina

Medina, Minnesota, United States

Site Status

Koetting Associates

St Louis, Missouri, United States

Site Status

Center for Ophthalmic and Vision Research

New York, New York, United States

Site Status

Optometry Group, PLLC

Memphis, Tennessee, United States

Site Status

Southern Utah Medical Research

St. George, Utah, United States

Site Status

Spokane Eye Clinic

Spokane, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLU484-N001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.